Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
- PMID: 30264411
- PMCID: PMC6282853
- DOI: 10.1002/ana.25346
Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
Abstract
Objective: Recent availability of amyloid and tau positron emission tomography (PET) has provided us with a unique opportunity to measure the association of systemic vascular health with brain health after accounting for the impact of Alzheimer disease (AD) pathologies. We wanted to quantify early cerebrovascular health-related magnetic resonance imaging brain measures (structure, perfusion, microstructural integrity) and evaluate their utility as a biomarker for cerebrovascular health.
Methods: We used 2 independent samples (discovery, n = 390; validation, n = 1,035) of individuals, aged ≥ 60 years, along the cognitive continuum with imaging from the population-based sample of Mayo Clinic Study of Aging. We ascertained vascular health by summing up recently existing cardiovascular and metabolic conditions (CMC) from health care records (hypertension, hyperlipidemia, cardiac arrhythmias, coronary artery disease, congestive heart failure, diabetes mellitus, and stroke). Using multiple regression models, we quantified associations between CMC and brain health after accounting for age, sex, education/occupation, and AD burden (from amyloid and tau PET).
Results: Systemic vascular health was associated with medial temporal lobe thinning, widespread cerebral hypoperfusion, and loss of microstructural integrity in several white matter tracts including the corpus callosum and fornix. Further investigations suggested that microstructural integrity of the genu of the corpus callosum was suitable for assessing prodromal cerebrovascular health, had similar distributions in the discovery and independent validation datasets, and predicted cognitive performance above and beyond amyloid deposition.
Interpretation: Systemic vascular health has significant impact on brain structure and function. Quantifying prodromal cerebrovascular health-related brain measures that are independent of AD pathology-related changes has great utility for cognitive aging. Ann Neurol 2018;84:713-724.
© 2018 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association.
Figures





References
-
- Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556–1560. - PubMed
-
- Carmelli D, Swan GE, Reed T, et al. Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology 1999;52:1119–1124. - PubMed
-
- DeCarli C, Miller BL, Swan GE, et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001;58:643–647. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG041851/AG/NIA NIH HHS/United States
- R01 AG056366/AG/NIA NIH HHS/United States
- R01 AG034676/AG/NIA NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- R01 AG56366/AG/NIA NIH HHS/United States
- U54 AG044170/AG/NIA NIH HHS/United States
- P50 AG16574/P1/AG/NIA NIH HHS/United States
- R01 AG11378/AG/NIA NIH HHS/United States
- U01 NS100620/NS/NINDS NIH HHS/United States
- U01 AG006786/AG/NIA NIH HHS/United States
- U01 AG06786/AG/NIA NIH HHS/United States
- C06 RR018898/RR/NCRR NIH HHS/United States
- R01 NS097495/AG/NIA NIH HHS/United States
- R01 AG011378/AG/NIA NIH HHS/United States
- C06 RR018898/NH/NIH HHS/United States
- RF1 AG057547/AG/NIA NIH HHS/United States
- R01 AG034676/NH/NIH HHS/United States
- R01 NS097495/NS/NINDS NIH HHS/United States
- P30 AG062677/AG/NIA NIH HHS/United States
- P50 AG16574/AG/NIA NIH HHS/United States
- R37 AG011378/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources